Researchers use CRISPR to "unlock" immune cells' power against solid tumors. In a mouse study, researchers found they can use CRISPR to delete a gene called FLI1 to enhance human killer cell survival after tumor infiltration.

By using CRISPR technology to delete a specific gene called FLI1, researchers were able to significantly enhance the ability of Natural Killer (NK) cells to survive and inhibit solid tumor growth.